The levels of HSD17B10 were found to be increased in 14 types of cancers, such as GBM, LGG, CESC, LUAD, COAD, BRCA, ESCA, STES, STAD, PRAD, UCEC, LUSC, READ, and BLCA. This evidence concerns the gene HSD17B10 and glioblastoma.